Impact of adjuvant trastuzumab on outcomes of HER2-positive breast cancer patients treated with HER2-targeted therapy in the metastatic setting.
Rashmi Krishna Murthy
Honoraria - Amgen
Ankur Varma
No relevant relationships to disclose
Priyankana Mishra
No relevant relationships to disclose
Kenneth R. Hess
No relevant relationships to disclose
Elliana J. Young
No relevant relationships to disclose
James L. Murray
No relevant relationships to disclose
Kimberly Higginbotham Koenig
No relevant relationships to disclose
Marjorie C. Green
No relevant relationships to disclose
Stacy L. Moulder
Honoraria - AstraZeneca (I); Roche (I); Sanofi (I); Wyeth (I)
Amal Melhem-Bertrandt
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Daniel J. Booser
No relevant relationships to disclose
Vicente Valero
No relevant relationships to disclose
Gabriel N. Hortobagyi
Consultant or Advisory Role - Genentech
Francisco J. Esteva
Consultant or Advisory Role - Genentech